Understanding XCL1: A Potential Drug Target and Biomarker (G6375)

Target Name: XCL1

NCBI ID: G6375

XCL1

Understanding XCL1: A Potential Drug Target and Biomarker

XCL1 (also known as SCM-1) is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

XCL1 has been shown to play a role in a number of important biological processes in the body, including the regulation of inflammation, blood vessel formation, and cell signaling. It is also involved in the development and maintenance of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

As a drug target, XCL1 is a promising target for a number of different diseases. For example, studies have shown that inhibiting XCL1 can reduce the growth and spread of cancer cells, and may also be effective in treating neurodegenerative diseases such as Alzheimer's and Parkinson's.

In addition to its potential as a drug target, XCL1 is also a potential biomarker for a number of diseases. Its expression has been shown to be elevated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, its levels have been shown to be correlated with the severity of certain diseases, such as heart failure in patients with cancer.

Despite the potential benefits of XCL1 as a drug target and biomarker, much more research is needed to fully understand its role in the body and its potential applications. continue to be explored. As research continues, it is likely that XCL1 will continue to be an important target for new drugs and therapies, and its potential as a biomarker for a number of diseases will also be discovered.

Protein Name: X-C Motif Chemokine Ligand 1

Functions: Chemotactic activity for lymphocytes but not for monocytes or neutrophils. In thymus, mediates medullary accumulation of thymic dendritic cells and contributes to regulatoy T cell development, playing a role in self-tolerance establishment

The "XCL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XCL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets